| Not Yet Recruiting | Efficacy and Safety of NVX-CoV2705 COVID-19, Sars-CoV-2 Infection | Phase 4 | 2025-11-10 |
| Withdrawn | Lot Consistency Study of COVID-19 and Influenza Combination Vaccine COVID-19, Influenza | Phase 2 / Phase 3 | 2025-02-01 |
| Active Not Recruiting | A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine COVID-19 | Phase 3 | 2024-12-09 |
| Withdrawn | Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine COVID-19 | Phase 2 / Phase 3 | 2024-11-01 |
| Completed | A Strain Change Study for SARS-CoV-2 rS Vaccines Severe Acute Respiratory Syndrome Coronavirus 2 Infection | Phase 3 | 2024-10-14 |
| Active Not Recruiting | Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection | Phase 4 | 2024-09-20 |
| Completed | Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines COVID-19 | Phase 2 / Phase 3 | 2023-10-16 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in COVID-19 | Phase 2 / Phase 3 | 2023-09-07 |
| Completed | Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines COVID-19 | Phase 3 | 2023-08-16 |
| Completed | Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines COVID-19 | Phase 3 | 2023-03-28 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine COVID-19, Influenza | Phase 2 | 2022-12-30 |
| Active Not Recruiting | Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years COVID-19 | Phase 2 / Phase 3 | 2022-07-22 |
| Completed | Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults COVID-19, SARS-CoV-2 Infection | Phase 3 | 2022-07-11 |
| Completed | Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines COVID-19, SARS CoV 2 Infection | Phase 3 | 2022-05-25 |
| Completed | A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS SARS-CoV-2 Infection | Phase 2 | 2022-02-28 |
| Withdrawn | Evaluation of the Safety and Immunogenicity of SII Vaccine Constructs Based on the SARS-CoV-2 (COVID-19) Varia Covid19 | Phase 1 / Phase 2 | 2022-02-04 |
| Completed | Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine SARS-CoV Infection, Covid19 | Phase 1 / Phase 2 | 2021-09-08 |
| Completed | A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With SARS-CoV Infection, Covid19 | Phase 3 | 2020-12-27 |
| Completed | A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the Unite SARS-CoV-2 Infection, COVID-19 | Phase 3 | 2020-09-28 |
| Completed | A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults SARS-CoV-2 Infection, COVID-19 | Phase 2 | 2020-08-17 |
| Completed | Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adju COVID-19 | Phase 1 / Phase 2 | 2020-05-25 |
| Completed | Phase 3 Pivotal Trial of NanoFlu™ in Older Adults Influenza, Human | Phase 3 | 2019-10-14 |
| Terminated | Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults Influenza, Human | Phase 2 | 2018-09-24 |
| Completed | Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Mat Influenza | Phase 1 / Phase 2 | 2017-09-18 |
| Completed | Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Alu Respiratory Syncytial Viruses | Phase 2 | 2017-01-01 |
| Completed | A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization Respiratory Syncytial Virus Infections | Phase 3 | 2015-12-01 |
| Completed | A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults Respiratory Syncytial Virus (RSV) | Phase 3 | 2015-11-01 |
| Completed | Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Pla Respiratory Syncytial Virus (RSV) | Phase 2 | 2015-10-01 |
| Completed | Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Ebola | Phase 1 | 2015-02-01 |
| Completed | A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age Respiratory Synctial Virus | Phase 1 | 2014-11-01 |
| Completed | Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults Influenza | Phase 2 | 2014-11-01 |
| Completed | Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults Respiratory Syncytial Virus (RSV) | Phase 2 | 2014-10-01 |
| Completed | RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women. Respiratory Syncytial Virus Infections | Phase 2 | 2014-09-01 |
| Completed | A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant Influenza (Pandemic) | Phase 1 / Phase 2 | 2014-03-01 |
| Completed | RSV F Dose-Ranging Study in Women Respiratory Syncytial Virus Infections | Phase 2 | 2013-10-01 |
| Completed | A(H7N9) VLP Antigen Dose Ranging Study With Adjuvant 1 Avian Influenza | Phase 1 | 2013-07-01 |
| Completed | RSV-F Vaccine Dose Ranging Study in Young Women Respiratory Syncytial Virus (RSV) | Phase 2 | 2012-10-01 |
| Completed | RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly Respiratory Syncytial Virus (RSV) | Phase 1 | 2012-10-01 |
| Completed | A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2 Influenza (Pandemic) | Phase 1 | 2012-05-01 |
| Completed | A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1 Influenza (Pandemic) | Phase 1 | 2012-04-01 |
| Completed | A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Heal Influenza | Phase 2 | 2012-03-01 |
| Completed | Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine Respiratory Syncytial Virus Infections | Phase 1 | 2010-12-01 |
| Completed | Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adul Influenza | Phase 2 | 2009-11-01 |
| Completed | Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine Seasonal Influenza | Phase 2 | 2009-10-01 |
| Completed | Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine Seasonal Influenza | Phase 2 | 2009-05-01 |
| Completed | Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults Influenza | Phase 2 | 2008-09-01 |
| Completed | Safety, Reactogenicity and Immunogenicity of an H5N1 VLP Pandemic Influenza | Phase 1 / Phase 2 | 2007-07-01 |